Company Quick10K Filing
Weyland Tech
10-Q 2020-06-30 Filed 2020-08-14
10-Q 2020-03-31 Filed 2020-05-15
10-K 2019-12-31 Filed 2020-03-30
10-Q 2019-09-30 Filed 2019-11-14
10-Q 2019-06-30 Filed 2019-08-14
10-Q 2019-03-31 Filed 2019-05-15
10-K 2018-12-31 Filed 2019-04-15
S-1 2018-12-17 Public Filing
10-Q 2018-09-30 Filed 2018-11-14
10-Q 2018-06-30 Filed 2018-08-14
10-Q 2018-03-31 Filed 2018-05-15
10-K 2017-12-31 Filed 2018-04-17
10-Q 2017-09-30 Filed 2017-11-14
10-Q 2017-06-30 Filed 2017-08-21
10-Q 2017-03-31 Filed 2017-05-15
10-K 2016-12-31 Filed 2017-03-31
10-Q 2016-09-30 Filed 2016-11-14
10-Q 2016-09-30 Filed 2016-11-14
10-Q 2016-06-30 Filed 2016-08-12
10-Q 2016-03-31 Filed 2016-05-23
10-K 2015-12-31 Filed 2016-04-14
10-Q 2015-09-30 Filed 2015-11-23
10-Q 2015-06-30 Filed 2015-08-11
10-Q 2015-03-31 Filed 2015-05-20
10-K 2014-12-31 Filed 2015-04-15
10-Q 2014-09-30 Filed 2014-11-19
10-Q 2014-06-30 Filed 2014-08-12
10-Q 2014-03-31 Filed 2014-05-07
10-K 2013-12-31 Filed 2014-03-27
10-Q 2013-09-30 Filed 2013-11-08
10-Q 2013-06-30 Filed 2013-08-09
10-Q 2013-03-31 Filed 2013-05-10
10-K 2012-12-31 Filed 2013-03-28
10-Q 2012-09-30 Filed 2012-10-22
10-Q 2012-08-08 Filed 2012-08-08
10-Q 2012-03-31 Filed 2012-05-09
10-K 2011-12-31 Filed 2012-03-27
8-K 2020-09-01 Officers, Regulation FD, Exhibits
8-K 2020-08-28 Regulation FD, Exhibits
8-K 2020-08-11 Enter Agreement, Regulation FD, Exhibits
8-K 2020-07-31 Amend Bylaw, Exhibits
8-K 2020-04-16
8-K 2020-03-25
8-K 2020-02-25
8-K 2020-01-08
8-K 2019-12-16
8-K 2019-11-25
8-K 2019-11-15
8-K 2019-08-19
8-K 2019-07-22
8-K 2018-10-05
8-K 2018-09-24
8-K 2018-09-20
8-K 2018-08-16
8-K 2018-02-12

Weyland Tech Financials

WEYL Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Rebel Group (REBL) 0% 0.0 -1,380% 703 4,933 140 0 -9,708 -9,660 -395
Generex Biotechnology (GNBT) 21% 0.0 -49% 52,240 43,297 1,764 374 -25,717 -18,297 -540
Poverty Dignified (POVD) 0.0 -4,053% 49 3,080 0 0 -2,000 -1,786 -41
Zhong Ya (WLUC) 0.0 0 63 0 0 -562 -562 -0
Weyland Tech (WEYL) 18% 2.2 -24% 11,699 2,218 24,630 4,372 -2,779 -2,702 -5,821
Longbau (LNGB) 4% -1.0 2% 10,660 10,136 4,882 210 165 222 -233
Scandium International Mining (SCY) 0.1 -171% 957 303 0 0 -1,636 -1,634 -219
Aprea Therapeutics (APRE) 8.4 -11% 57,336 9,943 0 0 -6,249 -6,249 -52,334
IntelliSense Solutions (INLL) 0.0 -7,286% 2 273 0 0 -178 -164 -2
Metropolitan Life Insurance (MLIC) 0% -1.8 1% 437,745,000 403,121,000 37,348,000 0 4,559,000 4,960,000 -8,986,000
Zeta Acquisition I (ZETAI) 0.2 -649% 4 324 0 0 -29 -18 -4
Ando Holdings (ANDO) 1.1 -74% 73 160 0 0 -54 -54 -61
Po Yuen Cultural (POYE) 0.0 -1,973% 1 68 0 0 -20 -20 -0
Advanced Biomedical Technologies (ABMT) 0.0 -321% 218 6,589 0 0 -701 -701 -11
Kyto Technology & Life Science (KBPH) 0% 0.8 -12% 2,578 66 15 0 -315 -315 -238
Federal Home Loan Bank of Topeka (FHLBT) 29.6 0% 57,131,130 54,472,808 0 0 132,964 1,095,234 32,380,961
CNL Healthcare Properties II (CHPII) 67% -4.4 68,889,100% 8,277 5,549 -689 1,137 -4,981
Original Source Music (OSMU) 0.0 743,400% 35 0 0 -7 -7 -0
Graham Alternative Investment Fund I (GAIF) -0.0 0% 29,076 1,126 0 0 0 5 -0
JiaLiJia Group (RZZN) 0.0 -1,721% 4 139 0 0 -69 -69 -0

Balance Sheet ($'000)2011-06-302011-09-302011-12-312012-03-312012-08-082012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-09-302018-12-312019-03-312019-06-302019-09-30
Cash664059143518306543516504297254304304472002,3801,7639491,0041,3501,2407601,0561,0099407311,3865,3035,821
Accounts Receivable7401,7347370000
Inventory
PP&E8865432210
Assets241347641487724685455175052972543043041686916313,8284,2715,4013,3965,4965,3185,9455,2976,2535,6905,4896,30710,60211,699
Accounts Payable13417341442942940406965270175474218181818888773
Long-Term Debt
Liabilities6003665184844994995124095474824364224054053829148571,9081,4611,8238441,4862,0202,7492,0473,0663093796395,2802,218
Stockholders' Equity-576-353-420-351273-45136-3023-139-169-101-101-214-223-2271,9202,8093,5782,5524,0103,2983,1953,2513,1865,3805,1095,6685,3239,482
Income Statement ($'000)2011-06-302011-09-302011-12-312012-03-312012-08-082012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue8,4368,4927,1428,996
Cost of Revenue3383125881,0181,7621,280629803402244543677969-336475956342,9931,7112,4341,0404,0553,2922,8805121,0336,9845,8747,400
Gross Profit-74272224490-337-209255596-35-99246674-14387551,6271,1401,0681,3351,7973135352,3953,6687,4031,5071,2681,597
R&D1,2094,5118681,2431,126
SG&A21956526423319224315822650425839227847517529514141743252622332512285539062,8784,8226411,6701,558
Tax0
Net Income-224-642-867-246307-639-36527200-290-492-32200-19195-9-91,3709207681,458-23-102-718-507-1,998-27-1,671-1,081
Cash Flow ($'000)2011-06-302011-09-302011-12-312012-03-312012-08-082012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating-34935-235-670-5528-147-48-458-435001680-4021,393-700-1,084127-18254-480-89-489692,591-4,722
Cash Investing000-157001630000000-100-60-110-72900000
Cash Financing349020050120322500000001,547-1,1503806573644425861,326